- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
4BASEBIO UK SOCIETAS (4BB)
4BASEBIO UK SOCIETAS stock price live, this page displays LON 4BB stock exchange data. View the 4BB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 4BASEBIO UK SOCIETAS real time stock price chart below.
What Is the 4BASEBIO UK SOCIETAS Stock Price Today?
The 4BASEBIO UK SOCIETAS stock price today is 900.00.
What Is the Stock Symbol for 4BASEBIO UK SOCIETAS?
The stock symbol for 4BASEBIO UK SOCIETAS is ""4BB.""
What Stock Exchange Does 4BASEBIO UK SOCIETAS Trade On?
4BASEBIO UK SOCIETAS is listed and trades on the London stock exchange.
Is 4BASEBIO UK SOCIETAS a Good Stock to Buy?
Determining whether 4BASEBIO UK SOCIETAS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4BB quote. (ISIN: GB00BMCLYF79)
What Is the 4BASEBIO UK SOCIETAS Stock Price Today?
The 4BASEBIO UK SOCIETAS stock price today is 900.00.
What Is the Stock Symbol for 4BASEBIO UK SOCIETAS?
The stock symbol for 4BASEBIO UK SOCIETAS is ""4BB.""
What Stock Exchange Does 4BASEBIO UK SOCIETAS Trade On?
4BASEBIO UK SOCIETAS is listed and trades on the London stock exchange.
Is 4BASEBIO UK SOCIETAS a Good Stock to Buy?
Determining whether 4BASEBIO UK SOCIETAS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4BB quote. (ISIN: GB00BMCLYF79)
London
Currency in GBP
900.00
-60.00(-6.25%)
Closed·
Fair Value
An estimate of a 4BASEBIO UK SOCIETAS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
870.00
980.00
52 wk Range
870.00
1,540.00
4BB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
1/3
Fair Value
An estimate of a 4BASEBIO UK SOCIETAS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
870.00980.00
52 wk Range
870.001,540.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4BB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a 4BASEBIO UK SOCIETAS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1,700.00
Upside
+88.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
4BASEBIO UK SOCIETAS Company Profile
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Compare 4BB to Peers and Sector
Metrics to compare | 4BB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4BBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.0x | −5.7x | −0.5x | |
PEG Ratio | 0.24 | −0.04 | 0.00 | |
Price/Book | 5.6x | 1.1x | 2.6x | |
Price / LTM Sales | 159.3x | 11.9x | 3.3x | |
Upside (Analyst Target) | 77.1% | 159.1% | 41.6% | |
Fair Value Upside | Unlock | 1.2% | 5.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,700.00
(+88.89% Upside)
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-0.49 / --
Revenue / Forecast
605.00K / --
FAQ
What Stock Exchange Does 4BASEBIO UK SOCIETAS Trade On?
4BASEBIO UK SOCIETAS is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for 4BASEBIO UK SOCIETAS?
The stock symbol for 4BASEBIO UK SOCIETAS is "4BB."
What Is the 4BASEBIO UK SOCIETAS Market Cap?
As of today, 4BASEBIO UK SOCIETAS market cap is 139.30M.
What Is 4BASEBIO UK SOCIETAS's Earnings Per Share (TTM)?
The 4BASEBIO UK SOCIETAS EPS (TTM) is -0.94.
When Is the Next 4BASEBIO UK SOCIETAS Earnings Date?
4BASEBIO UK SOCIETAS will release its next earnings report on 25 Sept 2025.
From a Technical Analysis Perspective, Is 4BB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has 4BASEBIO UK SOCIETAS Stock Split?
4BASEBIO UK SOCIETAS has split 0 times.
How Many Employees Does 4BASEBIO UK SOCIETAS Have?
4BASEBIO UK SOCIETAS has 110 employees.
What is the current trading status of 4BASEBIO UK SOCIETAS (4BB)?
As of 13 Aug 2025, 4BASEBIO UK SOCIETAS (4BB) is trading at a price of 900.00, with a previous close of 900.00. The stock has fluctuated within a day range of 870.00 to 980.00, while its 52-week range spans from 870.00 to 1,540.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.